
Abstract Background: This study aims to investigate the effects of tropicamide 1% on the main numerical parameters of anterior segment with the Pentacam rotating Scheimpflug camera in healthy individuals. Methods: Pentacam measurements of 50 (25 female and 25 male) healthy individuals before and after 25 min of tropicamide 1% instillation were performed and compared. For comparison of the test parameters, paired t -test was used in the groups. Results: Mean age in the study group was 28.40±4.58 years (range 18–35 years). Measurements between 2 sessions were significantly different for the parameters of anterior chamber depth (ACD) and anterior chamber volume (ACV) ( P <0.05). Conclusions: Tropicamide 1% instillation leads to a significant increment in ACD and ACV measurements. Effects of tropicamide on these parameters for Pentacam measurements should be considered to ensure exact clinical interpretation in ophthalmologic practice.
Adult, Male, Mydriatics, Adolescent, Anterior Chamber, Tropicamide, Young Adult, Anterior Eye Segment, Photography, Humans, Female, Prospective Studies
Adult, Male, Mydriatics, Adolescent, Anterior Chamber, Tropicamide, Young Adult, Anterior Eye Segment, Photography, Humans, Female, Prospective Studies
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 25 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
